Open | - |
Close | - |
Volume / Avg. | 0 / 408.604K |
Day Range | - - - |
52 Wk Range | 9.000 - 24.300 |
Market Cap | $735.642M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 10.35% |
Days to Cover | 12.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CryoPort (NASDAQ: CYRX) through any online brokerage.
Other companies in CryoPort’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
The latest price target for CryoPort (NASDAQ: CYRX) was reported by UBS on Friday, March 15, 2024. The analyst firm set a price target for 17.00 expecting CYRX to rise to within 12 months (a possible 13.18% upside). 17 analyst firms have reported ratings in the last year.
The stock price for CryoPort (NASDAQ: CYRX) is $15.02 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for CryoPort.
CryoPort’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for CryoPort.
CryoPort is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.